LEARN

The world is under a dizzying pressure to find a cure for the novel coronavirus that has affected over 14.5 million people worldwide and counting. While a vaccine is yet to be developed, researchers and doctors are looking for new ways to treat this deadly strain of the mutating virus.

According to the Anxiety and Depression Association of America, anxiety disorders affect 40 million adults across the country every year. That’s just over 18% of the population.

Migraine is a neurological condition that affects many people across the world. It is estimated to rank third in the global list of most common diseases after tension headache and dental caries.

They are continuously uncomfortable and in a painful state owing to the constant itching and inflammation they feel. These inflammatory skin conditions not only affect their quality of life but also severely hamper their self-esteem.

annabis and its many derivative compounds are a new wave in pharmaceuticals and dermatological formulations. Many brands that have not explored these until now are eager to get their feet wet in this promising new field. This change has come about thanks to more information, more research that is now available about these products.

Even though CBD is efficient in addressing a range of health conditions, poor bio-availability of the cannabinoid in oral administration prevents optimal utilization of CBD-based drugs.

CBD’s great performance in treating skin conditions led to further research and development in this area. After several years, CBD has now also been shown to be very effective in reducing inflammation in human sebocytes.

When a professional sportsperson or athlete gets injured, they need to heal and recover as soon as possible.